GM1 ganglioside induces vasodilation and increases catalase content in the brain

Free Radical Biology and Medicine

Volumn 43, Issue 6, 2007, Pages 924-932

  Furian, Ana Flávia ^a,b   Oliveira, Mauro Schneider ^a,b   Royes, Luiz Fernando Freire ^a   Fiorenza, Natália Gindri ^a   Fighera, Michele Rechia ^a   Myskiw, Jociane Carvalho ^a   Weiblen, Rudi ^a   Rubin, Maribel Antonello ^a   Frussa Filho, Roberto ^c   Mello, Carlos Fernando ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antioxidant; Catalase; Cortex; Free radicals; GM1 ganglioside; Hippocampus; Neurodegenerative diseases; Neuroprotection; Striatum; Vasodilation

Indexed keywords

CATALASE; GANGLIOSIDE GM1; HEMOGLOBIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN PERFUSION; BRAIN PROTECTION; BRAIN REGION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG MECHANISM; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; BRAIN; CATALASE; G(M1) GANGLIOSIDE; HEMOGLOBINS; MALE; RATS; RATS, WISTAR; VASODILATION;

ANIMALIA; RATTUS;

EID: 34547663157     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.05.035     Document Type: Article

References (56)

1. Ledeen R.W., and Yu R.K. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83 (1982) 139-191
2. Tettamanti G. Ganglioside/glycosphingolipid turnover: new concepts. Glycoconjugate J. 20 (2004) 301-317
3. Schengrund C.L. The role(s) of gangliosides in neural differentiation and repair: a perspective. Brain Res. Bull. 24 (1990) 131-141
4. Zeller C.B., and Marchase R.B. Gangliosides as modulators of cell function. Am. J. Physiol. 262 (1992) C1341-C1355
5. Perry J.C., Vital M.A., Frussa-Filho R., Tufik S., and Palermo-Neto J. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats. Eur. Neuropsychopharmacol. 14 (2004) 127-133
6. Goettl V.M., Zhang H., Burrows A.C., Wemlinger T.A., Neff N.H., and Hadjiconstantinou M. GM1 enhances dopaminergic markers in the brain of aged rats. Exp. Neurol. 183 (2003) 665-672
7. Rahmann H. Brain gangliosides and memory formation. Behav. Brain Res. 66 (1995) 105-116
8. Silva R.H., Felicio L.F., Nasello A.G., Vital M.A., and Frussa-Filho R. Effect of ganglioside (GM1) on memory in senescent rats. Neurobiol. Aging 17 (1996) 583-586
9. Fong T.G., Neff N.H., and Hadjiconstantinou M. GM1 ganglioside improves spatial learning and memory of aged rats. Behav. Brain Res. 85 (1997) 203-211
10. Wieraszko A., and Seifert W. The role of monosialoganglioside GM1 in the synaptic plasticity: in vitro study on rat hippocampal slices. Brain Res. 345 (1985) 159-164
11. Skaper S.D., Facci L., and Leon A. Gangliosides attenuate the delayed neurotoxicity of aspartic acid in vitro. Neurosci. Lett. 117 (1990) 154-159
12. Rothblat D.S., and Schneider J.S. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice. Ann. N. Y. Acad. Sci. 845 (1998) 274-277
13. Avrova N.F., Shestak K.I., Zakharova I.O., Sokolova T.V., Tyurina Y.Y., and Tyurin V.A. The use of antioxidants to prevent glutamate-induced derangement of calcium ion metabolism in rat cerebral cortex synaptosomes. Neurosci. Behav. Physiol. 30 (2000) 535-541
14. Wu G., Lu Z.H., Wang J., Wang Y., Xie X., Meyenhofer M.F., and Ledeen R.W. Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. J. Neurosci. 25 (2005) 11014-11022
15. Fighera M.R., Bonini J.S., de Oliveira T.G., Frussa-Filho R., Rocha J.B., Dutra-Filho C.S., Rubin M.A., and Mello C.F. GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int. J. Biochem. Cell. Biol. 35 (2003) 465-473
16. +-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiol. Dis. 22 (2006) 611-623
17. Tan W.K., Williams C.E., Gunn A.J., Mallard E.C., and Gluckman P.D. Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic-ischemic injury without causing systemic compromise. Pediatr. Res. 34 (1993) 18-22
18. Carolei A., Fieschi C., Bruno R., and Toffano G. Monosialoganglioside GM1 in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 3 (1991) 134-157
19. Krajnc D., Wemlinger T.A., Neff N.H., and Hadjiconstantinou M. Neonatal hypoxia: early neurotransmitter responses and the consequences of treatment with GM1 ganglioside. J. Pharmacol. Exp. Ther. 271 (1994) 1299-1305
20. Kwak D.H., Kim S.M., Lee D.H., Kim J.S., Kim S.M., Lee S.U., Jung K.Y., Seo B.B., and Choo Y.K. Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion. Mol. Cells 20 (2005) 354-360
21. Schneider J.S. GM1 ganglioside in the treatment of Parkinson's disease. Ann. N. Y. Acad. Sci. 845 (1998) 363-373
22. Yanagisawa K. Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta (2007) doi:10.1016/j.bbamem.2007.01.018
23. Svennerholm L. Gangliosides-A new therapeutic agent against stroke and Alzheimer's disease. Life Sci. 55 (1994) 2125-2134
24. Avrova N.F., Tyurin V.A., Tyurina Y., and Kagan V.E. Gangliosides in postischemic cellular dysfunctions. Ann. N. Y. Acad. Sci. 723 (1994) 353-355
25. Avrova N.F., Victorov I.V., Tyurin V.A., Zakharova I.O., Sokolova T.V., Andreeva N.A., Stelmaschuk E.V., Tyurina Y.Y., and Gonchar V.S. Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes. Neurochem. Res. 23 (1998) 945-952
26. Fighera M.R., Bonini J.S., Frussa-Filho R., Dutra-Filho C.S., Hagen M.E., Rubin M.A., and Mello C.F. Monosialoganglioside increases catalase activity in cerebral cortex of rats. Free Radic. Res. 38 (2004) 495-500
27. Maulik N., Das D.K., Gogineni M., Cordis G.A., Avrova N., and Denisova N. Reduction of myocardial ischemic reperfusion injury by sialylated glycosphingolipids, gangliosides. J. Cardiovasc. Pharmacol. 22 (1993) 74-81
28. Wassmann S., Wassmann K., and Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44 (2004) 381-386
29. 2-removing enzyme in human erythrocytes. Blood 90 (1997) 4973-4978
30. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9 (1995) 526-533
31. Moreno S., Mugnaini E., and Ceru M.P. Immunocytochemical localization of catalase in the central nervous system of the rat. J. Histochem. Cytochem. 43 (1995) 1253-1267
32. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
33. Hirrlinger J., Resch A., Gutterer J.M., and Dringen R. Oligodendroglial cells in culture effectively dispose of exogenous hydrogen peroxide: comparison with cultured neurones, astroglial and microglial cells. J. Neurochem. 82 (2002) 635-644
34. Henry J. Clinical diagnosis and management by laboratory methods (1991), Saunders, Philadelphia 553-560
35. Tallarida R., and Murray R. Manual of pharmacologic calculations with computer programs (1987), Springer-Verlag, New York 10-18
36. Duchemin A.M., Ren Q., Mo L., Neff N.H., and Hadjiconstantinou M. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J. Neurochem. 81 (2002) 696-707
37. Sobey C.G., and Quan L. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage. Am. J. Physiol. 277 (1999) H1718-H1724
38. Podoprigora G.I., Nartsissov Y.R., and Aleksandrov P.N. Effect of glycine on microcirculation in pial vessels of rat brain. Bull. Exp. Biol. Med. 139 (2005) 675-677
39. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
40. Rieke G.K., Bowers Jr. D.E., and Penn P. Vascular supply pattern to rat caudatoputamen and globus pallidus: scanning electron microscopic study of vascular endocasts of stroke-prone vessels. Stroke 12 (1981) 840-847
41. Boveris A., and Chance B. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem. J. 134 (1973) 707-716
42. Tanaka K., Dora E., Urbanics R., Greenberg J.H., Toffano G., and Reivich M. Effect of the ganglioside GM1, on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats. Stroke 17 (1986) 1170-1178
43. Chen Z.G., Lu Y.C., Zhu C., Zhang G.J., Ding X.H., and Jiang J.Y. Effects of ganglioside GM1 on reduction of brain edema and amelioration of cerebral metabolism after traumatic brain injury. Chin. J. Traumatol. 6 (2003) 23-27
44. Svennerholm L., Brane G., Karlsson I., Lekman A., Ramstrom I., and Wikkelso C. Alzheimer disease-Effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement. Geriatr. Cognit. Disord. 14 (2002) 128-136
45. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186 (1990) 1-85
46. Ho Y.S., Xiong Y., Ma W., Spector A., and Ho D.S. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J. Biol. Chem. 279 (2004) 32804-32812
47. Rabin S.J., Bachis A., and Mocchetti I. Gangliosides activate Trk receptors by inducing the release of neurotrophins. J. Biol. Chem. 277 (2002) 49466-49472
48. Takeo C., Nakamura S., Tanaka T., Uchida D., Noguchi Y., Nagao T., Saito Y., and Tatsuno I. Rat cerebral endothelial cells express trk C and are regulated by neurotrophin-3. Biochem. Biophys. Res. Commun. 305 (2003) 400-406
49. Thomas T., McLendon C., and Thomas G. l-Deprenyl: nitric oxide production and dilation of cerebral blood vessels. Neuroreport 9 (1998) 2595-2600
50. Rovere A.A., Raynald A.C., and Scremin O.U. On the mechanism of the amphetamine induced vasodilation at the rat's cerebral cortex. Experientia 33 (1977) 1461-1463
51. Carrillo M.C., Kanai S., Nokubo M., and Kitani K. (-) Deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci. 48 (1991) 517-521
52. Takahata K., Shimazu S., Katsuki H., Yoneda F., and Akaike A. Effects of selegiline on antioxidant systems in the nigrostriatum in rat. J. Neural Transm. 113 (2006) 151-158
53. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., and Quevedo J. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem. Res. 31 (2006) 699-703
54. Elder Jr. J.D., Nagano S.M., Eastwood D.W., and Harnagel D. Circulatory changes associated with thiopental anesthesia in man. Anesthesiology 16 (1955) 394-400
55. Etsten B., and Li T.H. Hemodynamic changes during thiopental anesthesia in humans: cardiac output, stroke volume, total peripheral resistance, and intrathoracic blood volume. J. Clin. Invest. 34 (1955) 500-510
56. Craigen M.L., and Jennett S. Pial arterial response to systemic hypoxia in anaesthetised cats. J. Cereb. Blood Flow Metab. 1 (1981) 285-296